Showing results (41-50 of 216) with videos related to
Sort By:
Pageof 22
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|October 16, 2020
European Stakeholder Learnings Regarding Biosimilars: Part II-Improving Biosimilar Use in Clinical PracticeLiese Barbier, Steven Simoens, Arnold G Vulto, et al.BMC Medical Ethics|August 1, 2021
Personalized and long-term electronic informed consent in clinical research: stakeholder viewsEvelien De Sutter, Pascal Borry, David Geerts, et al.Nature Biotechnology|October 10, 2009
Legal uncertainty in the area of genetic diagnostic testingIsabelle Huys, Nele Berthels, Gert Matthijs, et al.Acta Ophthalmologica|April 30, 2026
Exploring market dynamics of biological including biosimilar treatments for retinal diseases in Europe: An interrupted time-series analysisElif Car, Isabelle Huys, Steven Simoens, et al.Trials|July 10, 2026
Vulnerability, protection and fairness: ethical and regulatory limits in small-N gene therapy trialsMargaux Reckelbus, Eva Van Steijvoort, Isabelle Huys, et al.Frontiers in Medicine|June 13, 2022
Digitizing the Informed Consent Process: A Review of the Regulatory Landscape in the European UnionEvelien De Sutter, Janos Meszaros, Pascal Borry, et al.Applied Health Economics and Health Policy|August 3, 2016
Clinical, Economic and Policy Implications of Drug Shortages in the European UnionElfi De Weerdt, Steven Simoens, Minne Casteels, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 12, 2020
Shedding Light on Reimbursement Policies of Companion Diagnostics in European CountriesLaurenz Govaerts, Steven Simoens, Walter Van Dyck, et al.Frontiers in Pharmacology|November 19, 2015
Toward a European definition for a drug shortage: a qualitative studyElfi De Weerdt, Steven Simoens, Minne Casteels, et al.Clinical Drug Investigation|August 12, 2024
Budget Impact of Disease-Modifying Treatments and a CRISPR Gene-Edited Therapy for Sickle Cell DiseaseKhadidja Abdallah, Isabelle Huys, Kathleen J Claes, et al.Pageof 22